1. Home
  2. ACTG vs BNTC Comparison

ACTG vs BNTC Comparison

Compare ACTG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acacia Research Corporation (Acacia Tech)

ACTG

Acacia Research Corporation (Acacia Tech)

HOLD

Current Price

$4.27

Market Cap

440.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$9.59

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACTG
BNTC
Founded
1993
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.1M
396.3M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
ACTG
BNTC
Price
$4.27
$9.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
★ $27.67
AVG Volume (30 Days)
★ 167.8K
124.1K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 161.11
6.67
EPS
★ N/A
N/A
Revenue
★ $12,004,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.15
$9.26
52 Week High
$5.27
$16.76

Technical Indicators

Market Signals
Indicator
ACTG
BNTC
Relative Strength Index (RSI) 31.22 27.48
Support Level $3.86 N/A
Resistance Level $4.30 $13.49
Average True Range (ATR) 0.11 0.74
MACD -0.03 -0.24
Stochastic Oscillator 13.16 12.42

Price Performance

Historical Comparison
ACTG
BNTC

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations, and Manufacturing Operations. It derives revenue from the Intellectual Property Operations segment. Geographically, it operates in the Americas, Europe, the Middle East and Africa, China, India, and Asia-Pacific.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: